WBC
BEAT

Westpac Banking Corp’s BioTelemetry, Inc. BEAT Stock Holding History

Westpac Banking Corp’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-12,700
Closed -$368K – 972
2017
Q1 		$368K Buy
+12,700
New +$315K ﹤0.01% 861

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Westpac Banking Corp's BEAT Position: Q2 2017 in Review

Westpac Banking Corp sold out of BioTelemetry, Inc. (BEAT) in Q2 2017, closing a stake of 12,700 shares — an estimated $368K sold.

Westpac Banking Corp first reported a position in BEAT in Q1 2017 and held it in 1 quarter. The position peaked at $368K in Q1 2017. 195 funds tracked by Wall St. Rank hold BEAT as of Q2 2017.

  • Westpac Banking Corp reported no remaining BioTelemetry, Inc. position as of Q2 2017 after selling out during the quarter.
  • Westpac Banking Corp sold 12,700 BioTelemetry, Inc. shares in Q2 2017, an estimated $368K.
  • Westpac Banking Corp first reported a position in BioTelemetry, Inc. in Q1 2017 and held it in 1 quarter.
  • Westpac Banking Corp's BioTelemetry, Inc. position peaked at $368K in Q1 2017.
  • 195 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2017.

Based on Westpac Banking Corp's 13F filing for Q2 2017, filed 9 Aug 2017.